Investing.com - (NYSE:Allergan) Wednesday reported fourth-quarter earnings that beat estimates.
The maker of BOTOX posted a 16.1% rise in Q4 adjusted net income per share to $3.90.
Net revenues in the quarter climbed 7.1% from a year earlier to $3.86 bn.
The pharmaceutical firm was expected to report EPS of $3.76 on revenues of $3.81 bn.